Clinical trial

Pre-operative Zoledronate in Triple Negative Breast Cancer

NCT02347163

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2015-02-03

PhasePHASE2

Study timeline

Study start (actual)2015-02-03Date precision: day

Registry last updated2018-11-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

ZoledronateDRUG

Sponsors & collaborators

Mario Negri Institute for Pharmacological Researchlead sponsor

Associazione Italiana per la Ricerca sul Cancrocollaborator

Mapped research locations

PadovaItaly1 PaviaItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02347163 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.